Listas de Observação Ideias ProPicks IA Filtros Explorador de dados Gráficos Guardado

Dyne Therapeutics Inc

NASDAQGS:DYN

E.U.A. / Saúde / Biotecnologia

Resumo

Histórico Financeiro 10A

Preço Ação

11,41 USD


Key Metrics	Latest
Total Revenue	0 K
Adjusted EBITDA	-342,2 M
EBITDA Margin	NA
Net Profit Margin	NA
Total Assets	691,2 M
Total Debt	23,988 M

10Y Historical Financial Statements

Summary Financials


Summary Financials

	Fiscal Year Ending										Latest
(in millions)				Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	12 Months

Revenue	0	0	0	0	0	0	0	0	0	0	0
% Growth		NA	NA	NA	NA	NA	NA	NA	NA	NA

Adjusted EBITDA	0	0	0	(5)	(14)	(58)	(149)	(169)	(240)	(342)	(342)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Adjusted EBIT	0	0	0	(5)	(14)	(59)	(150)	(171)	(242)	(344)	(344)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Adjusted Net Income	0	0	0	(5)	(14)	(59)	(149)	(168)	(236)	(317)	(317)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Adjusted Basic EPS	NA	NA	NA	(10.12)	(5.68)	(4.13)	(2.93)	(3.23)	(3.95)	(3.37)	(3.37)

Cálculos de Suporte

Income Statement

Balance Sheet

Statement of Cashflows


Income Statement
											Original
USD	Fiscal Year Ending										Latest
(in millions)				Dec-18	Dec-19	Dec-20	Dec-21	Dec-22	Dec-23	Dec-24	Dec-24
	FY - 9	FY - 8	FY - 7	FY - 6	FY - 5	FY - 4	FY - 3	FY - 2	FY - 1	FY	LTM

Revenue	0	0	0	0	0	0	0	0	0	0	0
% Growth	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Cost of Revenue	0	0	0	0	0	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0	0
% Revenue	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Research and Development	0	0	0	(4)	(11)	(45)	(121)	(143)	(211)	(281)	(281)
Selling and Marketing	0	0	0	0	0	0	0	0	0	0	0
General and Admin	0	0	0	(1)	(3)	(13)	(29)	(28)	(31)	(62)	(62)
Other Inc / (Exp)	0	0	0	(0)	(1)	(0)	(0)	(0)	(1)	(0)	(0)
Total Operating Exp	0	0	0	(5)	(15)	(59)	(150)	(171)	(244)	(344)	(344)

Operating Income	0	0	0	(5)	(15)	(59)	(150)	(171)	(244)	(344)	(344)
% Revenue	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Interest Expense	0	0	0	0	0	(0)	1	3	8	27	27
Pre-tax Income	0	0	0	(5)	(15)	(59)	(149)	(168)	(236)	(317)	(317)
Earnings of Discontinued Ops.	0	0	0	0	0	0	0	0	0	0	0
Provision for Taxes	0	0	0	0	0	0	0	0	0	0	0
Net Income to Company	0	0	0	(5)	(15)	(59)	(149)	(168)	(236)	(317)	(317)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Minority Interest in Earnings	0	0	0	0	0	0	0	0	0	0	0
Net Income to Stockholders	0	0	0	(5)	(15)	(59)	(149)	(168)	(236)	(317)	(317)

Preferred Dividends	0	0	0	0	0	0	0	0	0	0	0
Other Adj.	0	0	0	0	0	0	0	0	0	0	0

Net Income to Common	0	0	0	(5)	(15)	(59)	(149)	(168)	(236)	(317)	(317)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

As Reported
Basic EPS (Continuing Ops)	0.00	0.00	0.00	(10.15)	(6.08)	(4.13)	(2.93)	(3.23)	(3.95)	(3.37)	(3.37)
Diluted EPS (Continuing Ops)	0.00	0.00	0.00	(10.15)	(6.08)	(4.13)	(2.93)	(3.23)	(3.95)	(3.37)	(3.37)

WA Basic Shares Out.	0.00	0.00	0.00	0.47	2.44	14.40	50.90	51.98	59.68	94.14	94.14
WA Diluted Shares Out.	0.00	0.00	0.00	0.47	2.44	14.40	50.90	51.98	59.68	94.14	94.14

EBITDA, EBIT Reconciliation
EBT, Incl. Unusual Items	0	0	0	(5)	(15)	(59)	(149)	(168)	(236)	(317)	(317)
Addback: Net Interest Expense	0	0	0	(0)	(0)	0	(1)	(3)	(8)	(27)	(27)
Addback: Other Non Operating Expenses, Total	0	0	0	0	0	0	0	0	1	0	0
Addback: Depreciation & Amortization	0	0	0	0	0	1	1	2	2	2	2
Addback: Restructuring Charges	0	0	0	0	0	0	0	0	0	0	0
Addback: Merger / Acquisition Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Goodwill Impairment	0	0	0	0	0	0	0	0	0	0	0
Addback: Gain (Loss) On Sale Of Invest.	0	0	0	0	0	0	0	0	0	(0)	(0)
Addback: Gain (Loss) On Sale Of Assets	0	0	0	0	0	0	0	0	0	0	0
Addback: Asset Writedown	0	0	0	0	0	0	0	0	0	0	0
Addback: In Process R&D Expenses	0	0	0	0	0	0	0	0	0	0	0
Addback: Insurance Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Legal Settlements	0	0	0	0	0	0	0	0	0	0	0
Addback: Other Unusual Items	0	0	0	0	1	0	0	0	0	0	0
Adjusted EBITDA	0	0	0	(5)	(14)	(58)	(149)	(169)	(240)	(342)	(342)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Adjusted EBIT	0	0	0	(5)	(14)	(59)	(150)	(171)	(242)	(344)	(344)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Adjusted Net Income Reconciliation
Net Income to Company	0	0	0	(5)	(15)	(59)	(149)	(168)	(236)	(317)	(317)
Addback: Unusual Items	0	0	0	0	1	0	0	0	0	(0)	(0)
Less: Tax Benefit of Unusual Items (26%)	0	0	0	(0)	(0)	0	(0)	(0)	(0)	0	0
Adjusted Net Income	0	0	0	(5)	(14)	(59)	(149)	(168)	(236)	(317)	(317)
% Margin	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

Erro de carregamento

Dyne Therapeutics Inc

NASDAQGS:DYN

E.U.A. / Saúde / Biotecnologia

Histórico Financeiro 10A